HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

作者: R. Kleemann , T. Kooistra

DOI: 10.2174/156800605774962077

关键词:

摘要: Besides classical risk factors such as hypercholesterolemia and hypertension, chronic subacute inflammation has recently been recognized an important force driving the development of atherosclerosis, most common underlying cause myocardial infarction stroke. There is compelling evidence that a disturbance cholesterol homeostasis contributes to inflammatory state inhibitors HMG-CoA reductase (statins) may dampen inappropriate responses. We review suggest mechanisms by which dietary can induce atherogenic response in liver vessel wall, with particular emphasis on time course this during atherogenesis interplay between these tissues. discuss how statins interfere process, whether they reduce via a) their cholesterol-lowering effect, and/or b) cholesterol-independent (pleiotropic) vasculoprotective activities. Recent studies performed (humanized) animal models allow us distinguish lipid-lowering-dependent from lipid-lowering-independent functions statins. Using data, we degree effects contribute reduction inflammation, allowing estimation relevance pleiotropic statin for human situation.

参考文章(118)
Daniel J. Rader, A new feature on the cholesterol-lowering landscape Nature Medicine. ,vol. 7, pp. 1282- 1284 ,(2001) , 10.1038/NM1201-1282
Masakatsu Ohtawa, Naoki Masuda, Izumi Akasaka, Akinori Nakashima, Keiko Ochiai, Matsuko Moriyasu, Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells. British Journal of Clinical Pharmacology. ,vol. 47, pp. 383- 389 ,(1999) , 10.1046/J.1365-2125.1999.00901.X
Dongsheng Cai, Minsheng Yuan, Daniel F Frantz, Peter A Melendez, Lone Hansen, Jongsoon Lee, Steven E Shoelson, Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB Nature Medicine. ,vol. 11, pp. 183- 190 ,(2005) , 10.1038/NM1166
Riichiro Abe, Tina Peng, Joseph Sailors, Richard Bucala, Christine N. Metz, Regulation of the CTL Response by Macrophage Migration Inhibitory Factor The Journal of Immunology. ,vol. 166, pp. 747- 753 ,(2001) , 10.4049/JIMMUNOL.166.2.747
Qingyu Wu, Zuchun Zhao, Inhibition of PAI-1: a new anti-thrombotic approach. Current Drug Targets - Cardiovascular & Hematological Disorders. ,vol. 2, pp. 27- 42 ,(2002) , 10.2174/1568006023337727
Robert Kleemann, Angelika Hausser, Georg Geiger, Ralf Mischke, Anke Burger-Kentischer, Oliver Flieger, Franz-Josef Johannes, Thierry Roger, Thierry Calandra, Aphrodite Kapurniotu, Matthias Grell, Doris Finkelmeier, Herwig Brunner, Jürgen Bernhagen, Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 Nature. ,vol. 408, pp. 211- 216 ,(2000) , 10.1038/35041591
J R Smith, T F Osborne, J L Goldstein, M S Brown, Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene Journal of Biological Chemistry. ,vol. 265, pp. 2306- 2310 ,(1990) , 10.1016/S0021-9258(19)39976-4
Robert Kleemann, Hans Rorsman, Evald Rosengren, Ralf Mischke, Nguyen Tuyet Mai, Jürgen Bernhagen, Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor. Full immunologic activity of N-terminally truncated mutants. FEBS Journal. ,vol. 267, pp. 7183- 7193 ,(2000) , 10.1046/J.1432-1327.2000.01823.X
Birgit WEINHOLD, Ulrich RÜTHER, Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene Biochemical Journal. ,vol. 327, pp. 425- 429 ,(1997) , 10.1042/BJ3270425